MONTREAL and CHARLOTTE, N.C., Sept. 8, 2020 /CNW/ -- Milestone
Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical
company focused on the development and commercialization of
innovative cardiovascular medicines, today announced
that Joseph Oliveto, President and Chief Executive Officer,
will present at the following investor conferences:
- The H.C. Wainwright & Co. 22nd Annual Global
Investment Conference on Tuesday, September
15, 2020 at 11:30 a.m. Eastern
Time
- The Oppenheimer Fall Healthcare Life Sciences & MedTech
Summit on Wednesday, September 23,
2020 at 2:30 p.m. Eastern
Time
A live webcast of the presentations can be accessed in the News
& Events section of Milestone's website
at www.milestonepharma.com. An archived replay of the webcasts
will be available on the same website for approximately 30 days
following the presentations.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company
focused on the development and commercialization of innovative
cardiovascular medicines. Milestone
Pharmaceuticals operates in Canada and the
United States. For more
information, visit www.milestonepharma.com and follow the
Company on Twitter at @MilestonePharma.
Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301124643.html
SOURCE Milestone Pharmaceuticals, Inc.